Industry Research Reports
Home > Reports > Medical Devices & Consumables > Viral Transduction Enhancer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Viral Transduction Enhancer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-03-10
Pages: 123 Pages
Report ld: 4617439
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Viral Transduction Enhancer was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
A Viral Transduction Enhancer refers to a substance or method that increases the efficiency with which a virus introduces genetic material into a host cell. In gene therapy and research, viral transduction is a common technique used to deliver therapeutic genes or other genetic elements into cells. Enhancers in this context can include chemical compounds, modifications to the virus, or specific environmental conditions that improve the virus's ability to enter the host cell, thereby increasing the success rate of gene delivery and expression. These enhancers are crucial in optimizing the effectiveness of viral-based gene therapies and related biotechnological applications.
North American market for Viral Transduction Enhancer was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Viral Transduction Enhancer was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Viral Transduction Enhancer was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Viral Transduction Enhancer include Thermo Fisher Scientific, Applied Biological Materials, Takara Bio, OZ Biosciences, Revvity, Bio-Techne, Virongy, BPS Bioscience, System Biosciences, Miltenyi Biotec, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Viral Transduction Enhancer, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Viral Transduction Enhancer by region & country, by Type, and by Application.
The Viral Transduction Enhancer market size, estimations, and forecasts are provided in terms of sales volume (kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Transduction Enhancer.
MARKET SEGMENTATION
By Company
- Thermo Fisher Scientific
- Applied Biological Materials
- Takara Bio
- OZ Biosciences
- Revvity
- Bio-Techne
- Virongy
- BPS Bioscience
- System Biosciences
- Miltenyi Biotec
- komabiotech
- ABP Biosciences
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Retrovirus (RV)
- Adenovirus (AdV)
- Adeno-associated Virus (AAV)
Segment by Application
- Hospitals
- Clinical Laboratories
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Viral Transduction Enhancer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Viral Transduction Enhancer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Viral Transduction Enhancer in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Viral Transduction Enhancer Product Introduction
1.2 Global Viral Transduction Enhancer Market Size Forecast
1.2.1 Global Viral Transduction Enhancer Sales Value (2020-2031)
1.2.2 Global Viral Transduction Enhancer Sales Volume (2020-2031)
1.2.3 Global Viral Transduction Enhancer Sales Price (2020-2031)
1.3 Viral Transduction Enhancer Market Trends & Drivers
1.3.1 Viral Transduction Enhancer Industry Trends
1.3.2 Viral Transduction Enhancer Market Drivers & Opportunity
1.3.3 Viral Transduction Enhancer Market Challenges
1.3.4 Viral Transduction Enhancer Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Viral Transduction Enhancer Players Revenue Ranking (2024)
2.2 Global Viral Transduction Enhancer Revenue by Company (2020-2025)
2.3 Global Viral Transduction Enhancer Players Sales Volume Ranking (2024)
2.4 Global Viral Transduction Enhancer Sales Volume by Company Players (2020-2025)
2.5 Global Viral Transduction Enhancer Average Price by Company (2020-2025)
2.6 Key Manufacturers Viral Transduction Enhancer Manufacturing Base and Headquarters
2.7 Key Manufacturers Viral Transduction Enhancer Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Viral Transduction Enhancer
2.9 Viral Transduction Enhancer Market Competitive Analysis
2.9.1 Viral Transduction Enhancer Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Viral Transduction Enhancer Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Transduction Enhancer as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Retrovirus (RV)
3.1.2 Adenovirus (AdV)
3.1.3 Adeno-associated Virus (AAV)
3.2 Global Viral Transduction Enhancer Sales Value by Type
3.2.1 Global Viral Transduction Enhancer Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Viral Transduction Enhancer Sales Value, by Type (2020-2031)
3.2.3 Global Viral Transduction Enhancer Sales Value, by Type (%) (2020-2031)
3.3 Global Viral Transduction Enhancer Sales Volume by Type
3.3.1 Global Viral Transduction Enhancer Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Viral Transduction Enhancer Sales Volume, by Type (2020-2031)
3.3.3 Global Viral Transduction Enhancer Sales Volume, by Type (%) (2020-2031)
3.4 Global Viral Transduction Enhancer Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinical Laboratories
4.1.3 Others
4.2 Global Viral Transduction Enhancer Sales Value by Application
4.2.1 Global Viral Transduction Enhancer Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Viral Transduction Enhancer Sales Value, by Application (2020-2031)
4.2.3 Global Viral Transduction Enhancer Sales Value, by Application (%) (2020-2031)
4.3 Global Viral Transduction Enhancer Sales Volume by Application
4.3.1 Global Viral Transduction Enhancer Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Viral Transduction Enhancer Sales Volume, by Application (2020-2031)
4.3.3 Global Viral Transduction Enhancer Sales Volume, by Application (%) (2020-2031)
4.4 Global Viral Transduction Enhancer Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Viral Transduction Enhancer Sales Value by Region
5.1.1 Global Viral Transduction Enhancer Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Viral Transduction Enhancer Sales Value by Region (2020-2025)
5.1.3 Global Viral Transduction Enhancer Sales Value by Region (2026-2031)
5.1.4 Global Viral Transduction Enhancer Sales Value by Region (%), (2020-2031)
5.2 Global Viral Transduction Enhancer Sales Volume by Region
5.2.1 Global Viral Transduction Enhancer Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Viral Transduction Enhancer Sales Volume by Region (2020-2025)
5.2.3 Global Viral Transduction Enhancer Sales Volume by Region (2026-2031)
5.2.4 Global Viral Transduction Enhancer Sales Volume by Region (%), (2020-2031)
5.3 Global Viral Transduction Enhancer Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Viral Transduction Enhancer Sales Value, 2020-2031
5.4.2 North America Viral Transduction Enhancer Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Viral Transduction Enhancer Sales Value, 2020-2031
5.5.2 Europe Viral Transduction Enhancer Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Viral Transduction Enhancer Sales Value, 2020-2031
5.6.2 Asia Pacific Viral Transduction Enhancer Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Viral Transduction Enhancer Sales Value, 2020-2031
5.7.2 South America Viral Transduction Enhancer Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Viral Transduction Enhancer Sales Value, 2020-2031
5.8.2 Middle East & Africa Viral Transduction Enhancer Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Viral Transduction Enhancer Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Viral Transduction Enhancer Sales Value and Sales Volume
6.2.1 Key Countries/Regions Viral Transduction Enhancer Sales Value, 2020-2031
6.2.2 Key Countries/Regions Viral Transduction Enhancer Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Viral Transduction Enhancer Sales Value, 2020-2031
6.3.2 United States Viral Transduction Enhancer Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Viral Transduction Enhancer Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Viral Transduction Enhancer Sales Value, 2020-2031
6.4.2 Europe Viral Transduction Enhancer Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Viral Transduction Enhancer Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Viral Transduction Enhancer Sales Value, 2020-2031
6.5.2 China Viral Transduction Enhancer Sales Value by Type (%), 2024 VS 2031
6.5.3 China Viral Transduction Enhancer Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Viral Transduction Enhancer Sales Value, 2020-2031
6.6.2 Japan Viral Transduction Enhancer Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Viral Transduction Enhancer Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Viral Transduction Enhancer Sales Value, 2020-2031
6.7.2 South Korea Viral Transduction Enhancer Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Viral Transduction Enhancer Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Viral Transduction Enhancer Sales Value, 2020-2031
6.8.2 Southeast Asia Viral Transduction Enhancer Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Viral Transduction Enhancer Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Viral Transduction Enhancer Sales Value, 2020-2031
6.9.2 India Viral Transduction Enhancer Sales Value by Type (%), 2024 VS 2031
6.9.3 India Viral Transduction Enhancer Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Information
7.1.2 Thermo Fisher Scientific Introduction and Business Overview
7.1.3 Thermo Fisher Scientific Viral Transduction Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Thermo Fisher Scientific Viral Transduction Enhancer Product Offerings
7.1.5 Thermo Fisher Scientific Recent Development
7.2 Applied Biological Materials
7.2.1 Applied Biological Materials Company Information
7.2.2 Applied Biological Materials Introduction and Business Overview
7.2.3 Applied Biological Materials Viral Transduction Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Applied Biological Materials Viral Transduction Enhancer Product Offerings
7.2.5 Applied Biological Materials Recent Development
7.3 Takara Bio
7.3.1 Takara Bio Company Information
7.3.2 Takara Bio Introduction and Business Overview
7.3.3 Takara Bio Viral Transduction Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Takara Bio Viral Transduction Enhancer Product Offerings
7.3.5 Takara Bio Recent Development
7.4 OZ Biosciences
7.4.1 OZ Biosciences Company Information
7.4.2 OZ Biosciences Introduction and Business Overview
7.4.3 OZ Biosciences Viral Transduction Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 OZ Biosciences Viral Transduction Enhancer Product Offerings
7.4.5 OZ Biosciences Recent Development
7.5 Revvity
7.5.1 Revvity Company Information
7.5.2 Revvity Introduction and Business Overview
7.5.3 Revvity Viral Transduction Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Revvity Viral Transduction Enhancer Product Offerings
7.5.5 Revvity Recent Development
7.6 Bio-Techne
7.6.1 Bio-Techne Company Information
7.6.2 Bio-Techne Introduction and Business Overview
7.6.3 Bio-Techne Viral Transduction Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Bio-Techne Viral Transduction Enhancer Product Offerings
7.6.5 Bio-Techne Recent Development
7.7 Virongy
7.7.1 Virongy Company Information
7.7.2 Virongy Introduction and Business Overview
7.7.3 Virongy Viral Transduction Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Virongy Viral Transduction Enhancer Product Offerings
7.7.5 Virongy Recent Development
7.8 BPS Bioscience
7.8.1 BPS Bioscience Company Information
7.8.2 BPS Bioscience Introduction and Business Overview
7.8.3 BPS Bioscience Viral Transduction Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 BPS Bioscience Viral Transduction Enhancer Product Offerings
7.8.5 BPS Bioscience Recent Development
7.9 System Biosciences
7.9.1 System Biosciences Company Information
7.9.2 System Biosciences Introduction and Business Overview
7.9.3 System Biosciences Viral Transduction Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 System Biosciences Viral Transduction Enhancer Product Offerings
7.9.5 System Biosciences Recent Development
7.10 Miltenyi Biotec
7.10.1 Miltenyi Biotec Company Information
7.10.2 Miltenyi Biotec Introduction and Business Overview
7.10.3 Miltenyi Biotec Viral Transduction Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Miltenyi Biotec Viral Transduction Enhancer Product Offerings
7.10.5 Miltenyi Biotec Recent Development
7.11 komabiotech
7.11.1 komabiotech Company Information
7.11.2 komabiotech Introduction and Business Overview
7.11.3 komabiotech Viral Transduction Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 komabiotech Viral Transduction Enhancer Product Offerings
7.11.5 komabiotech Recent Development
7.12 ABP Biosciences
7.12.1 ABP Biosciences Company Information
7.12.2 ABP Biosciences Introduction and Business Overview
7.12.3 ABP Biosciences Viral Transduction Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 ABP Biosciences Viral Transduction Enhancer Product Offerings
7.12.5 ABP Biosciences Recent Development
8 Industry Chain Analysis
8.1 Viral Transduction Enhancer Industrial Chain
8.2 Viral Transduction Enhancer Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Viral Transduction Enhancer Sales Model
8.5.2 Sales Channel
8.5.3 Viral Transduction Enhancer Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Viral Transduction Enhancer Market Trends
Table 2. Viral Transduction Enhancer Market Drivers & Opportunity
Table 3. Viral Transduction Enhancer Market Challenges
Table 4. Viral Transduction Enhancer Market Restraints
Table 5. Global Viral Transduction Enhancer Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Viral Transduction Enhancer Revenue Market Share by Company (2020-2025)
Table 7. Global Viral Transduction Enhancer Sales Volume by Company (2020-2025) & (kg)
Table 8. Global Viral Transduction Enhancer Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Viral Transduction Enhancer Price by Company (2020-2025) & (US$/kg)
Table 10. Key Manufacturers Viral Transduction Enhancer Manufacturing Base and Headquarters
Table 11. Key Manufacturers Viral Transduction Enhancer Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Viral Transduction Enhancer
Table 13. Global Viral Transduction Enhancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Transduction Enhancer as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Viral Transduction Enhancer Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Viral Transduction Enhancer Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Viral Transduction Enhancer Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Viral Transduction Enhancer Sales Market Share in Value by Type (2020-2025)
Table 20. Global Viral Transduction Enhancer Sales Market Share in Value by Type (2026-2031)
Table 21. Global Viral Transduction Enhancer Sales Volume by Type: 2020 VS 2024 VS 2031 (kg)
Table 22. Global Viral Transduction Enhancer Sales Volume by Type (2020-2025) & (kg)
Table 23. Global Viral Transduction Enhancer Sales Volume by Type (2026-2031) & (kg)
Table 24. Global Viral Transduction Enhancer Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Viral Transduction Enhancer Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Viral Transduction Enhancer Price by Type (2020-2025) & (US$/kg)
Table 27. Global Viral Transduction Enhancer Price by Type (2026-2031) & (US$/kg)
Table 28. Global Viral Transduction Enhancer Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Viral Transduction Enhancer Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Viral Transduction Enhancer Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Viral Transduction Enhancer Sales Market Share in Value by Application (2020-2025)
Table 32. Global Viral Transduction Enhancer Sales Market Share in Value by Application (2026-2031)
Table 33. Global Viral Transduction Enhancer Sales Volume by Application: 2020 VS 2024 VS 2031 (kg)
Table 34. Global Viral Transduction Enhancer Sales Volume by Application (2020-2025) & (kg)
Table 35. Global Viral Transduction Enhancer Sales Volume by Application (2026-2031) & (kg)
Table 36. Global Viral Transduction Enhancer Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Viral Transduction Enhancer Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Viral Transduction Enhancer Price by Application (2020-2025) & (US$/kg)
Table 39. Global Viral Transduction Enhancer Price by Application (2026-2031) & (US$/kg)
Table 40. Global Viral Transduction Enhancer Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Viral Transduction Enhancer Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Viral Transduction Enhancer Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Viral Transduction Enhancer Sales Value by Region (2020-2025) & (%)
Table 44. Global Viral Transduction Enhancer Sales Value by Region (2026-2031) & (%)
Table 45. Global Viral Transduction Enhancer Sales Volume by Region (kg): 2020 VS 2024 VS 2031
Table 46. Global Viral Transduction Enhancer Sales Volume by Region (2020-2025) & (kg)
Table 47. Global Viral Transduction Enhancer Sales Volume by Region (2026-2031) & (kg)
Table 48. Global Viral Transduction Enhancer Sales Volume by Region (2020-2025) & (%)
Table 49. Global Viral Transduction Enhancer Sales Volume by Region (2026-2031) & (%)
Table 50. Global Viral Transduction Enhancer Average Price by Region (2020-2025) & (US$/kg)
Table 51. Global Viral Transduction Enhancer Average Price by Region (2026-2031) & (US$/kg)
Table 52. Key Countries/Regions Viral Transduction Enhancer Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Viral Transduction Enhancer Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Viral Transduction Enhancer Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Viral Transduction Enhancer Sales Volume, (2020-2025) & (kg)
Table 56. Key Countries/Regions Viral Transduction Enhancer Sales Volume, (2026-2031) & (kg)
Table 57. Thermo Fisher Scientific Company Information
Table 58. Thermo Fisher Scientific Introduction and Business Overview
Table 59. Thermo Fisher Scientific Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 60. Thermo Fisher Scientific Viral Transduction Enhancer Product Offerings
Table 61. Thermo Fisher Scientific Recent Development
Table 62. Applied Biological Materials Company Information
Table 63. Applied Biological Materials Introduction and Business Overview
Table 64. Applied Biological Materials Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 65. Applied Biological Materials Viral Transduction Enhancer Product Offerings
Table 66. Applied Biological Materials Recent Development
Table 67. Takara Bio Company Information
Table 68. Takara Bio Introduction and Business Overview
Table 69. Takara Bio Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 70. Takara Bio Viral Transduction Enhancer Product Offerings
Table 71. Takara Bio Recent Development
Table 72. OZ Biosciences Company Information
Table 73. OZ Biosciences Introduction and Business Overview
Table 74. OZ Biosciences Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 75. OZ Biosciences Viral Transduction Enhancer Product Offerings
Table 76. OZ Biosciences Recent Development
Table 77. Revvity Company Information
Table 78. Revvity Introduction and Business Overview
Table 79. Revvity Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 80. Revvity Viral Transduction Enhancer Product Offerings
Table 81. Revvity Recent Development
Table 82. Bio-Techne Company Information
Table 83. Bio-Techne Introduction and Business Overview
Table 84. Bio-Techne Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 85. Bio-Techne Viral Transduction Enhancer Product Offerings
Table 86. Bio-Techne Recent Development
Table 87. Virongy Company Information
Table 88. Virongy Introduction and Business Overview
Table 89. Virongy Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 90. Virongy Viral Transduction Enhancer Product Offerings
Table 91. Virongy Recent Development
Table 92. BPS Bioscience Company Information
Table 93. BPS Bioscience Introduction and Business Overview
Table 94. BPS Bioscience Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 95. BPS Bioscience Viral Transduction Enhancer Product Offerings
Table 96. BPS Bioscience Recent Development
Table 97. System Biosciences Company Information
Table 98. System Biosciences Introduction and Business Overview
Table 99. System Biosciences Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 100. System Biosciences Viral Transduction Enhancer Product Offerings
Table 101. System Biosciences Recent Development
Table 102. Miltenyi Biotec Company Information
Table 103. Miltenyi Biotec Introduction and Business Overview
Table 104. Miltenyi Biotec Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 105. Miltenyi Biotec Viral Transduction Enhancer Product Offerings
Table 106. Miltenyi Biotec Recent Development
Table 107. komabiotech Company Information
Table 108. komabiotech Introduction and Business Overview
Table 109. komabiotech Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 110. komabiotech Viral Transduction Enhancer Product Offerings
Table 111. komabiotech Recent Development
Table 112. ABP Biosciences Company Information
Table 113. ABP Biosciences Introduction and Business Overview
Table 114. ABP Biosciences Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 115. ABP Biosciences Viral Transduction Enhancer Product Offerings
Table 116. ABP Biosciences Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Viral Transduction Enhancer Downstream Customers
Table 120. Viral Transduction Enhancer Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Viral Transduction Enhancer Product Picture
Figure 2. Global Viral Transduction Enhancer Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Viral Transduction Enhancer Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Viral Transduction Enhancer Sales Volume (2020-2031) & (kg)
Figure 5. Global Viral Transduction Enhancer Sales Price (2020-2031) & (US$/kg)
Figure 6. Viral Transduction Enhancer Report Years Considered
Figure 7. Global Viral Transduction Enhancer Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Viral Transduction Enhancer Players Sales Volume Ranking (2024) & (kg)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Viral Transduction Enhancer Revenue in 2024
Figure 10. Viral Transduction Enhancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Retrovirus (RV) Picture
Figure 12. Adenovirus (AdV) Picture
Figure 13. Adeno-associated Virus (AAV) Picture
Figure 14. Global Viral Transduction Enhancer Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Viral Transduction Enhancer Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Viral Transduction Enhancer Sales Volume by Type (2020 VS 2024 VS 2031) & (kg)
Figure 17. Global Viral Transduction Enhancer Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Viral Transduction Enhancer Price by Type (2020-2031) & (US$/kg)
Figure 19. Product Picture of Hospitals
Figure 20. Product Picture of Clinical Laboratories
Figure 21. Product Picture of Others
Figure 22. Global Viral Transduction Enhancer Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Viral Transduction Enhancer Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Viral Transduction Enhancer Sales Volume by Application (2020 VS 2024 VS 2031) & (kg)
Figure 25. Global Viral Transduction Enhancer Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Viral Transduction Enhancer Price by Application (2020-2031) & (US$/kg)
Figure 27. North America Viral Transduction Enhancer Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Viral Transduction Enhancer Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Viral Transduction Enhancer Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Viral Transduction Enhancer Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Viral Transduction Enhancer Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Viral Transduction Enhancer Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Viral Transduction Enhancer Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Viral Transduction Enhancer Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Viral Transduction Enhancer Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Viral Transduction Enhancer Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Viral Transduction Enhancer Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Viral Transduction Enhancer Sales Volume (%), (2020-2031)
Figure 39. United States Viral Transduction Enhancer Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Viral Transduction Enhancer Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Viral Transduction Enhancer Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Viral Transduction Enhancer Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Viral Transduction Enhancer Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Viral Transduction Enhancer Sales Value by Application (%), 2024 VS 2031
Figure 45. China Viral Transduction Enhancer Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Viral Transduction Enhancer Sales Value by Type (%), 2024 VS 2031
Figure 47. China Viral Transduction Enhancer Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Viral Transduction Enhancer Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Viral Transduction Enhancer Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Viral Transduction Enhancer Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Viral Transduction Enhancer Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Viral Transduction Enhancer Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Viral Transduction Enhancer Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Viral Transduction Enhancer Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Viral Transduction Enhancer Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Viral Transduction Enhancer Sales Value by Application (%), 2024 VS 2031
Figure 57. India Viral Transduction Enhancer Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Viral Transduction Enhancer Sales Value by Type (%), 2024 VS 2031
Figure 59. India Viral Transduction Enhancer Sales Value by Application (%), 2024 VS 2031
Figure 60. Viral Transduction Enhancer Industrial Chain
Figure 61. Viral Transduction Enhancer Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Viral Transduction Enhancer market?
The top companies in the global Viral Transduction Enhancer market are Thermo Fisher Scientific、Applied Biological Materials、Takara Bio.
Related Reports
Global Viral Transduction Enhancer Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Viral Transduction Enhancer market is projected to grow from US$ 169 million in 2025 to US$ 241 million by 2032, at a CAGR of 5.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-17
Pages: 174
USD 4900.00
(Single User License)
Global Viral Transduction Enhancer Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Viral Transduction Enhancer market size was US$ 169 million in 2025 and is forecast to reach a readjusted size of US$ 241 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published Date: 2026-07-17
Pages: 155
USD 4250.00
(Single User License)
Viral Transduction Enhancer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Viral Transduction Enhancer was estimated to be worth US$ 169 million in 2025 and is projected to reach US$ 241 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-07-17
Pages: 147
USD 3950.00
(Single User License)
Global Viral Transduction Enhancer Market Research Report 2026
The global Viral Transduction Enhancer market was valued at US$ 169 million in 2025 and is anticipated to reach US$ 241 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-07-17
Pages: 132
USD 2900.00
(Single User License)
Global Viral Transduction Enhancer Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Viral Transduction Enhancer market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 166
USD 4900.00
(Single User License)
Global Viral Transduction Enhancer Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Viral Transduction Enhancer market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 100
USD 4250.00
(Single User License)
Global Viral Transduction Enhancer Market Research Report 2025
The global market for Viral Transduction Enhancer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 89
USD 2900.00
(Single User License)
Global Viral Transduction Enhancer Market Research Report 2024
A Viral Transduction Enhancer refers to a substance or method that increases the efficiency with which a virus introduces genetic material into a host cell. In gene therapy and research, viral transduction is a common technique used to deliver therapeutic genes or other genetic elements into cells. Enhancers in this context can include chemical compounds, modifications to the virus, or specific environmental conditions that improve the virus's ability to enter the host cell, thereby increasing the success rate of gene delivery and expression. These enhancers are crucial in optimizing the effectiveness of viral-based gene therapies and related biotechnological applications.
Published Date: 2024-08-24
Pages: 97
USD 2900.00
(Single User License)
Global and United States Viral Transduction Enhancer Market Report & Forecast 2024-2030
A Viral Transduction Enhancer refers to a substance or method that increases the efficiency with which a virus introduces genetic material into a host cell. In gene therapy and research, viral transduction is a common technique used to deliver therapeutic genes or other genetic elements into cells. Enhancers in this context can include chemical compounds, modifications to the virus, or specific environmental conditions that improve the virus's ability to enter the host cell, thereby increasing the success rate of gene delivery and expression. These enhancers are crucial in optimizing the effectiveness of viral-based gene therapies and related biotechnological applications.
Published Date: 2024-08-24
Pages: 123
USD 4350.00
(Single User License)
Global Viral Transduction Enhancer Market Insights, Forecast to 2030
A Viral Transduction Enhancer refers to a substance or method that increases the efficiency with which a virus introduces genetic material into a host cell. In gene therapy and research, viral transduction is a common technique used to deliver therapeutic genes or other genetic elements into cells. Enhancers in this context can include chemical compounds, modifications to the virus, or specific environmental conditions that improve the virus's ability to enter the host cell, thereby increasing the success rate of gene delivery and expression. These enhancers are crucial in optimizing the effectiveness of viral-based gene therapies and related biotechnological applications.
Published Date: 2024-08-24
Pages: 149
USD 4900.00
(Single User License)
Global Viral Transduction Enhancer Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Viral Transduction Enhancer market is projected to grow from US$ 169 million in 2025 to US$ 241 million by 2032, at a CAGR of 5.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-17
Pages: 174
USD 4900.00 (Single User License)Global Viral Transduction Enhancer Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Viral Transduction Enhancer market size was US$ 169 million in 2025 and is forecast to reach a readjusted size of US$ 241 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published: 2026-07-17
Pages: 155
USD 4250.00 (Single User License)Viral Transduction Enhancer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Viral Transduction Enhancer was estimated to be worth US$ 169 million in 2025 and is projected to reach US$ 241 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-07-17
Pages: 147
USD 3950.00 (Single User License)Global Viral Transduction Enhancer Market Research Report 2026
The global Viral Transduction Enhancer market was valued at US$ 169 million in 2025 and is anticipated to reach US$ 241 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-07-17
Pages: 132
USD 2900.00 (Single User License)Global Viral Transduction Enhancer Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Viral Transduction Enhancer market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 166
USD 4900.00 (Single User License)Global Viral Transduction Enhancer Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Viral Transduction Enhancer market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 100
USD 4250.00 (Single User License)Global Viral Transduction Enhancer Market Research Report 2025
The global market for Viral Transduction Enhancer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 89
USD 2900.00 (Single User License)Global Viral Transduction Enhancer Market Research Report 2024
A Viral Transduction Enhancer refers to a substance or method that increases the efficiency with which a virus introduces genetic material into a host cell. In gene therapy and research, viral transduction is a common technique used to deliver therapeutic genes or other genetic elements into cells. Enhancers in this context can include chemical compounds, modifications to the virus, or specific environmental conditions that improve the virus's ability to enter the host cell, thereby increasing the success rate of gene delivery and expression. These enhancers are crucial in optimizing the effectiveness of viral-based gene therapies and related biotechnological applications.
Published: 2024-08-24
Pages: 97
USD 2900.00 (Single User License)Global and United States Viral Transduction Enhancer Market Report & Forecast 2024-2030
A Viral Transduction Enhancer refers to a substance or method that increases the efficiency with which a virus introduces genetic material into a host cell. In gene therapy and research, viral transduction is a common technique used to deliver therapeutic genes or other genetic elements into cells. Enhancers in this context can include chemical compounds, modifications to the virus, or specific environmental conditions that improve the virus's ability to enter the host cell, thereby increasing the success rate of gene delivery and expression. These enhancers are crucial in optimizing the effectiveness of viral-based gene therapies and related biotechnological applications.
Published: 2024-08-24
Pages: 123
USD 4350.00 (Single User License)Global Viral Transduction Enhancer Market Insights, Forecast to 2030
A Viral Transduction Enhancer refers to a substance or method that increases the efficiency with which a virus introduces genetic material into a host cell. In gene therapy and research, viral transduction is a common technique used to deliver therapeutic genes or other genetic elements into cells. Enhancers in this context can include chemical compounds, modifications to the virus, or specific environmental conditions that improve the virus's ability to enter the host cell, thereby increasing the success rate of gene delivery and expression. These enhancers are crucial in optimizing the effectiveness of viral-based gene therapies and related biotechnological applications.
Published: 2024-08-24
Pages: 149
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now